Characteristics Associated with Long-Acting Naltrexone Treatment Persistence

被引：0
|
作者：
Chang, Grace [1 ]
Schein, Abigail [1 ]
Crawford, Mitchell [2 ]
机构：
[1] Harvard Med Sch, Boston, MA USA
[2] Harvard South Shore Psychiat Residency Training P, Brockton, MA USA
来源：
AMERICAN JOURNAL ON ADDICTIONS | 2018年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：273 / 274
页数：2
相关论文
共 50 条
  • [31] Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone
    Dunbar, JL
    Turncliff, RZ
    Dong, QM
    Silverman, BL
    Ehrich, EW
    Lasseter, KC
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (03) : 480 - 490
  • [32] Participation in counseling and recovery activities during pharmacotherapy with injectable long-acting naltrexone
    Zweben, Allen
    Gastfriend, D. R.
    Loewy, J.
    Silverman, B.
    Ehrich, E.
    AMERICAN JOURNAL ON ADDICTIONS, 2006, 15 (04): : 322 - 322
  • [33] PLASMA CORTICOSTEROID LEVELS IN RATS MAINTAINED ON A LONG-ACTING NALTREXONE DELIVERY SYSTEM
    MISRA, AL
    PONTANI, RB
    VADLAMANI, NL
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1978, 20 (01): : 43 - 50
  • [34] New therapeutic options for alcohol dependence: Long-acting intramuscular formulations of naltrexone
    Garbutt, James C.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 : 30 - 34
  • [35] Adherence and Persistence to Long-Acting Anticholinergics Treatment Episodes in Patients With Chronic Obstructive Pulmonary Disease
    Savaria, Francois
    Beauchesne, Marie-France
    Forget, Amelie
    Blais, Lucie
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (12) : 1063 - 1068
  • [36] Characteristics and treatment pathways of patients with COPD receiving a long-acting muscarinic antagonist/long-acting β2-agonist (LABA/LAMA) in the UK
    Requena, Gema
    Banks, Victoria
    Czira, Alexandrosz
    Wood, Robert
    Tritton, Theo
    Ha, Eunmi
    Wild, Rosie
    Compton, Chris
    Ismaila, Afisi
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [37] LONG-ACTING AND SHORT-ACTING DIURETICS IN THE TREATMENT OF HYPERTENSION
    PUPITA, F
    BELOGI, M
    ANSUINI, R
    CAMPOLUCCI, G
    PHARMATHERAPEUTICA, 1983, 3 (07) : 475 - 481
  • [38] Serious adverse events and death associated with treatment using long-acting β-agonists
    Martinez, Fernando D.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2006, 31 (2-3) : 269 - 278
  • [39] Serious adverse events and death associated with treatment using long-acting β-agonists
    Fernando D. Martinez
    Clinical Reviews in Allergy & Immunology, 2006, 31 : 269 - 278
  • [40] Intrinsically long-acting agents compared with long-acting chronoformulations
    Meredith, PA
    BLOOD PRESSURE MONITORING, 2000, 5 : S25 - S30
12345